CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western studyFast Track Designation granted by FDA for CRB-701 to ...

Aveo Pharmaceutical spokesperson has denied allegations made by BBC that it was engaged in the export of opioids to West Africa. The company said in a statement that  "In response to the allegations ...

It is chasing after Vertex Pharma’s VX-548 ... of rinatabart sesutecan (Rina-S), a folate receptor-alpha targeted ADC, which is also in development for endometrial cancer.

At the front of its pipeline is ADCE-T02, a "highly differentiated" anti-tissue factor (TF) ADC that Adcendo licensed ... with applications across the pharma, food, and chemical sectors.

MaxLinear, the MaxLinear logo, any other MaxLinear trademarks are all property ... Treatment for Type 1 Diabetes TIXiMED Inc. (www.tiximed.com), a clinical-stage pharmaceutical company based on the ...

This combination is licenced by the relevant State Food and Drug Administration (FDA) and is exported under the necessary NOC from the Assistant Drug Controllers (ADC ... been using Aveo ...

The Indian government has taken decisive action against Aveo Pharmaceuticals Ltd (Aveo) after a BBC investigation alleged ... with the necessary NOC from the assistant drug controllers (ADC) and an ...

At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the "Most Promising ADC Clinical Candidate in Taiwan" award. This recognition follows OBI Pharma’s ...

Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its ...

Beyond novel ADC designs, it is notable that novel ADC ... In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for ...

Massachusetts-based Corbus licensed the Nectin-4-directed ADC in 2023. The deal saw China’s CSPC Pharmaceutical grant Corbus rights to the drug candidate in markets including the U.S. and the EU ...